Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Shentu (CTK) vs Injective (INJ) Price & Performance

Price performance (Past 24H)

Key statistics

Shentu vs Injective — how do they compare? Shentu trades at Rp1,886 (market cap Rp307,89M, Rp22,45M 24h volume), while Injective trades at Rp75,948 (market cap Rp7,68T, Rp1,11T 24h volume). The key difference: Injective is far larger — about 24944× Shentu's market cap, and Shentu's circulating supply is 162,7M CTK versus 100M INJ for Injective. Which is the better fit depends on your goals — on Pluang, investors hold Shentu for 44 Days and Injective for 37 Days on average.

CTKINJ
Market Cap
Rp307,89MRp7,68T
Volume (24h)
Rp22,45MRp1,11T
Circulating Supply
162,7M CTK100M INJ
Typical Hold Time
44 Days37 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Shentu

Shentu (CTK) is trading at Rp1,849 with a market cap of Rp301.81 million, showing a bullish overall signal driven by oscillators, while moving averages indicate bearish pressure. Key technical levels place support at Rp1,811 and resistance at Rp1,950. The token's 44-day average hold time suggests moderate holding behavior among investors. No major protocol updates or ecosystem news were noted recently, keeping fundamental developments quiet.

Outlook: CTK presents a cautious buy opportunity with bullish momentum but faces resistance near Rp1,950. Risks include low liquidity and crypto market volatility. Investors should monitor volume trends and regulatory shifts in the Indonesian crypto space, as thin trading could amplify price swings.

Injective

Injective (INJ) is currently trading at Rp75,554 with a market cap of Rp7.49T, exhibiting a bearish technical signal as indicated by moving averages. The asset trades below its pivot point of Rp82,186, with key support at Rp81,456 and resistance at Rp82,576. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding behavior.

The overall outlook is cautious due to bearish technical indicators and neutral oscillators. Key opportunities lie in potential rebounds from support levels, while major risks include high volatility and the absence of recent significant protocol updates. Investors should monitor trading volume and broader crypto market trends closely.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CTK
52% Buy48% Sell
Avg holding period · 44 Days
INJ
63% Buy37% Sell
Avg holding period · 37 Days

Top news

Latest headlines on both assets

About Shentu

Shentu Chain, a security-first, delegated proof-of-stake blockchain, for trustworthy execution of mission-critical applications, including DeFi, NFTs, and autonomous vehicles. Shentu Chain prioritizes cross-chain compatibility, built as a Cosmos Hub with full EVM and Hyperledger Burrow compatibility, as well as compatibility with eWASM and Ant Financial’s AntChain.

Read more on CTK

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ